In the News: Prolia; Topical NSAIDs; Gout Drug & Type 2 Diabetes; Osteoarthritis

Delaying Doses of Prolia Boosts Risk for Spine Fractures Denosumab (Prolia®) is a drug used for postmenopausal women and men who have the bone-thinning disease osteoporosis. It is given as an injection every six months. This drug is effective for preserving bone density. Discontinuing it can lead to a reversal of its effects. A study […]
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Arthritis Advisor

Get the next year of Arthritis Advisor for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 36%. It's like getting 4 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access